Vinorelbine in Unresectable or Metastatic Esophageal and Gastric Adenocarcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00215462
Recruitment Status : Completed
First Posted : September 22, 2005
Last Update Posted : April 28, 2009
Brigham and Women's Hospital
Massachusetts General Hospital
Beth Israel Deaconess Medical Center
Information provided by:
Dana-Farber Cancer Institute

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : August 2005
  Study Completion Date : August 2005